P. Vajro et al., Lack of efficacy of ursodeoxycholic acid for the treatment of liver abnormalities in obese children, J PEDIAT, 136(6), 2000, pp. 739-743
Objective: To determine whether ursodeoxycholic acid (UDCA) is effective fo
r treatment of obesity-related liver abnormalities in children.
Study design: Thirty-one children (21 boys; mean age, 8.7 years) had obesit
y-related persistent elevation of aminotransferase levels, which was associ
ated with ultrasonographic images of bright liver in 27. A preliminary inte
rview determined which patients were (n = 18) or were not (n = 13) likely t
o comply with a balanced low-calorie diet. Four subgroups emerged: patients
who followed the diet (n = 11), patients treated with UDCA (10 mg/kg/d) gi
ven alone (n = 7) or added to the diet (n = 7), and untreated control patie
nts (n=6)
Results: Diet alone determined weight loss and resolved biochemical liver a
bnormalities in all patients. Addition of UDCA to the diet was no more effi
cacious than weight loss alone. UDCA alone was ineffective for the treatmen
t of liver abnormalities in all cases, and results did not differ from thos
e observed in the untreated control group. Improvement of ultrasonographic
abnormalities was observed in patients who lost weight, irrespective of UDC
A administration.
Conclusions: UDCA is not effective for the treatment of obesity-related liv
er abnormalities in children.